Cargando…

Endothelial progenitor cells display clonal restriction in multiple myeloma

BACKGROUND: In multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, importantly, covary with disease activity and response to treatment. In order to unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Braunstein, Marc, Özçelik, Tayfun, Bağişlar, Sevgi, Vakil, Varsha, Smith, Eric LP, Dai, Kezhi, Akyerli, Cemaliye B, Batuman, Olcay A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557670/
https://www.ncbi.nlm.nih.gov/pubmed/16790068
http://dx.doi.org/10.1186/1471-2407-6-161
_version_ 1782129392685678592
author Braunstein, Marc
Özçelik, Tayfun
Bağişlar, Sevgi
Vakil, Varsha
Smith, Eric LP
Dai, Kezhi
Akyerli, Cemaliye B
Batuman, Olcay A
author_facet Braunstein, Marc
Özçelik, Tayfun
Bağişlar, Sevgi
Vakil, Varsha
Smith, Eric LP
Dai, Kezhi
Akyerli, Cemaliye B
Batuman, Olcay A
author_sort Braunstein, Marc
collection PubMed
description BACKGROUND: In multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, importantly, covary with disease activity and response to treatment. In order to understand the mechanisms responsible for increased EPC levels and neoangiogenic function in MM, we investigated whether these cells were clonal by determining X-chromosome inactivation (XCI) patterns in female patients by a human androgen receptor assay (HUMARA). In addition, EPCs and bone marrow cells were studied for the presence of clonotypic immunoglobulin heavy-chain (IGH) gene rearrangement, which indicates clonality in B cells; thus, its presence in EPCs would indicate a close genetic link between tumor cells in MM and endothelial cells that provide tumor neovascularization. METHODS: A total of twenty-three consecutive patients who had not received chemotherapy were studied. Screening in 18 patients found that 11 displayed allelic AR in peripheral blood mononuclear cells, and these patients were further studied for XCI patterns in EPCs and hair root cells by HUMARA. In 2 patients whose EPCs were clonal by HUMARA, and in an additional 5 new patients, EPCs were studied for IGH gene rearrangement using PCR with family-specific primers for IGH variable genes (V(H)). RESULTS: In 11 patients, analysis of EPCs by HUMARA revealed significant skewing (≥ 77% expression of a single allele) in 64% (n = 7). In 4 of these patients, XCI skewing was extreme (≥ 90% expression of a single allele). In contrast, XCI in hair root cells was random. Furthermore, PCR amplification with V(H )primers resulted in amplification of the same product in EPCs and bone marrow cells in 71% (n = 5) of 7 patients, while no IGH rearrangement was found in EPCs from healthy controls. In addition, in patients with XCI skewing in EPCs, advanced age was associated with poorer clinical status, unlike patients whose EPCs had random XCI. CONCLUSION: Our results suggest that EPCs in at least a substantial subpopulation of MM patients are related to the neoplastic clone and that this is an important mechanism for upregulation of tumor neovascularization in MM.
format Text
id pubmed-1557670
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15576702006-08-31 Endothelial progenitor cells display clonal restriction in multiple myeloma Braunstein, Marc Özçelik, Tayfun Bağişlar, Sevgi Vakil, Varsha Smith, Eric LP Dai, Kezhi Akyerli, Cemaliye B Batuman, Olcay A BMC Cancer Research Article BACKGROUND: In multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, importantly, covary with disease activity and response to treatment. In order to understand the mechanisms responsible for increased EPC levels and neoangiogenic function in MM, we investigated whether these cells were clonal by determining X-chromosome inactivation (XCI) patterns in female patients by a human androgen receptor assay (HUMARA). In addition, EPCs and bone marrow cells were studied for the presence of clonotypic immunoglobulin heavy-chain (IGH) gene rearrangement, which indicates clonality in B cells; thus, its presence in EPCs would indicate a close genetic link between tumor cells in MM and endothelial cells that provide tumor neovascularization. METHODS: A total of twenty-three consecutive patients who had not received chemotherapy were studied. Screening in 18 patients found that 11 displayed allelic AR in peripheral blood mononuclear cells, and these patients were further studied for XCI patterns in EPCs and hair root cells by HUMARA. In 2 patients whose EPCs were clonal by HUMARA, and in an additional 5 new patients, EPCs were studied for IGH gene rearrangement using PCR with family-specific primers for IGH variable genes (V(H)). RESULTS: In 11 patients, analysis of EPCs by HUMARA revealed significant skewing (≥ 77% expression of a single allele) in 64% (n = 7). In 4 of these patients, XCI skewing was extreme (≥ 90% expression of a single allele). In contrast, XCI in hair root cells was random. Furthermore, PCR amplification with V(H )primers resulted in amplification of the same product in EPCs and bone marrow cells in 71% (n = 5) of 7 patients, while no IGH rearrangement was found in EPCs from healthy controls. In addition, in patients with XCI skewing in EPCs, advanced age was associated with poorer clinical status, unlike patients whose EPCs had random XCI. CONCLUSION: Our results suggest that EPCs in at least a substantial subpopulation of MM patients are related to the neoplastic clone and that this is an important mechanism for upregulation of tumor neovascularization in MM. BioMed Central 2006-06-22 /pmc/articles/PMC1557670/ /pubmed/16790068 http://dx.doi.org/10.1186/1471-2407-6-161 Text en Copyright © 2006 Braunstein et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Braunstein, Marc
Özçelik, Tayfun
Bağişlar, Sevgi
Vakil, Varsha
Smith, Eric LP
Dai, Kezhi
Akyerli, Cemaliye B
Batuman, Olcay A
Endothelial progenitor cells display clonal restriction in multiple myeloma
title Endothelial progenitor cells display clonal restriction in multiple myeloma
title_full Endothelial progenitor cells display clonal restriction in multiple myeloma
title_fullStr Endothelial progenitor cells display clonal restriction in multiple myeloma
title_full_unstemmed Endothelial progenitor cells display clonal restriction in multiple myeloma
title_short Endothelial progenitor cells display clonal restriction in multiple myeloma
title_sort endothelial progenitor cells display clonal restriction in multiple myeloma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557670/
https://www.ncbi.nlm.nih.gov/pubmed/16790068
http://dx.doi.org/10.1186/1471-2407-6-161
work_keys_str_mv AT braunsteinmarc endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT ozceliktayfun endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT bagislarsevgi endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT vakilvarsha endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT smithericlp endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT daikezhi endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT akyerlicemaliyeb endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma
AT batumanolcaya endothelialprogenitorcellsdisplayclonalrestrictioninmultiplemyeloma